| Followers | 66 |
| Posts | 7188 |
| Boards Moderated | 1 |
| Alias Born | 02/02/2017 |
Wednesday, May 06, 2026 9:45:04 AM
Strong news.
Bullish
Recent VNRX News
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets • PR Newswire (US) • 05/27/2026 12:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:00:21 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:05:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:21:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:18:53 PM
- VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update • PR Newswire (US) • 05/14/2026 08:10:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/13/2026 08:15:13 PM
- VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update • PR Newswire (US) • 05/11/2026 12:19:00 PM
- VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats • PR Newswire (US) • 05/06/2026 12:17:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:45:39 PM
- Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing • PR Newswire (US) • 04/29/2026 12:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:45:52 PM
- VolitionRx Announces Acceptance of Compliance Plan by NYSE American • PR Newswire (US) • 04/23/2026 12:12:00 PM
- Volition Launches rNuQ™ Webshop Broadening Product Range • PR Newswire (US) • 04/20/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 09:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:30:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:12:43 PM
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update • PR Newswire (US) • 03/31/2026 08:05:00 PM
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium • PR Newswire (US) • 03/31/2026 12:16:00 PM
- Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients • PR Newswire (US) • 03/30/2026 12:13:00 PM
- Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference • PR Newswire (US) • 03/26/2026 12:17:00 PM
- VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update • PR Newswire (US) • 03/25/2026 08:12:00 PM
- Volition Announces Detection of Over 95% of Early-Stage Cancers • PR Newswire (US) • 03/25/2026 12:17:00 PM
